title: Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels.
abstract: Most investigations into cancer cell drug response are performed with cells cultured on flat (2D) tissue culture plastic. Emerging research has shown that the presence of a three-dimensional (3D) extracellular matrix (ECM) is critical for normal cell behavior including migration, adhesion, signaling, proliferation and apoptosis. In this study we investigate differences between cancer cell signaling in 2D culture and a 3D ECM, employing real-time, live cell tracking to directly observe U2OS human osteosarcoma and MCF7 human breast cancer cells embedded in type 1 collagen gels. The activation of the important PI3K signaling pathway under these different growth conditions is studied, and the response to inhibition of both PI3K and mTOR with PI103 investigated. Cells grown in 3D gels show reduced proliferation and migration as well as reduced PI3K pathway activation when compared to cells grown in 2D. Our results quantitatively demonstrate that a collagen ECM can protect U2OS cells from PI103. Overall, our data suggests that 3D gels may provide a better medium for investigation of anti-cancer drugs than 2D monolayers, therefore allowing better understanding of cellular response and behavior in native like environments.
authors.affiliation: Department of Biomedical Engineering, Boston University, Boston, Massachusetts, United States of America.
authors.forename: Brian
authors.initials: B
authors.lastname: Fallica
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Maffei
authors.forename: Shaun
authors.initials: S
authors.lastname: Villa
authors.forename: Guy
authors.initials: G
authors.lastname: Makin
authors.forename: Muhammad
authors.initials: M
authors.lastname: Zaman
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D015153:Blotting, Western; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology; D018929:Cell Culture Techniques / Q000379:methods*; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D024042:Collagen Type I / Q000378:metabolism* / Q000494:pharmacology; D005109:Extracellular Matrix / Q000378:metabolism / Q000502:physiology; D005663:Furans / Q000494:pharmacology; D005782:Gels; D006801:Humans; D061986:MCF-7 Cells; D018613:Microscopy, Confocal; D018715:Microscopy, Video; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism
chemical_list: D024042:Collagen Type I; D005663:Furans; D005782:Gels; D019869:Phosphatidylinositol 3-Kinases; D011725:Pyridines; D011743:Pyrimidines; D058570:TOR Serine-Threonine Kinases; C522973:PI103; C546842:MTOR protein, human